Bringing the fundamentals into focus…
Back to PTC Therapeutics, Inc.
How PTC Therapeutics, Inc. stacks up
PTCT · against 223 other Healthcare companies of similar size
Valuation
44/ 100
Below the middle of the pack.
Ranked #135 of 224 · scores higher than 38% of peers
Bars: peers in each 10-point band of the valuation score30 peers with a valuation score of 40–49, including PTCT · Click a bar to see the companies
Why valuation scores 44?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.7% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -0.7% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 4.8% vs peer median 4.0%
Metric by metric
Position: dot = PTCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PTCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 221 reported | -1.0% | 2.5% | 28% | 30% | |
| EBITDA yieldHigher is better · 222 reported | 2.6% | 4.5% | 38% | 50% | |
| Free cash flow yieldHigher is better · 125 reported | -5.8% | 1.0% | 10% | 20% | |
| Book yieldHigher is better · 223 reported | -2.9% | 24.5% | 1% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PTCT| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 4 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 135 | 21.6B CNY (≈$3.0B) | 44 | 41 | |
| 135 | 10.5B USD | 44 | 56 | |
| 135 | 321.5B INR (≈$3.9B) | 44 | 70 | |
| 135 | 871.6B INR (≈$10.5B) | 44 | 66 | |
| 135 | 5.7B USD | 44 | 38 | |
| 135 | 5.9B USD | 44 | 39 | |
| 141 | 40.3B SEK (≈$4.0B) | 43 | 79 | |
| 141 | 4.6B USD | 43 | 65 | |
| 143 | 5.1B USD | 42 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score